Drug intelligence / Profile preview

purified protein derivative

Development stage
Unknown
Lead developer
Assiut University
Modality
Recombinant Proteins and Enzymes
Administration
Intralesional
01

Overview

Purified protein derivative (PPD) is a biologic extract of soluble proteins derived from *Mycobacterium tuberculosis* cultures. While traditionally utilized as a diagnostic reagent for tuberculosis skin testing (the Mantoux test), it is being investigated by Assiut University as a form of intralesional immunotherapy for the treatment of recalcitrant warts, including palmoplantar warts. When injected intralesionally, PPD acts as a non-specific immunostimulant that triggers a potent localized cell-mediated immune response (Type IV hypersensitivity). This immune activation facilitates the recognition and subsequent clearance of human papillomavirus (HPV)-infected keratinocytes. Clinical research, including Phase 4 randomized trials, has demonstrated that intralesional PPD can achieve high complete clearance rates in patients with difficult-to-treat palmoplantar warts, often serving as a cost-effective alternative to other treatments like bleomycin.

Brand names
TubersolAplisol
Other names
PPDtuberculin purified protein derivativetuberculin PPDtuberculin
02

Targets

TLR2 (Toll-like Receptor 2)

Beyond the preview

Go deeper on purified protein derivative.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on purified protein derivative.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call